Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 49 | 2024 | 2423 | 7.220 |
Why?
|
Breast Neoplasms | 68 | 2024 | 21056 | 4.680 |
Why?
|
Ultrasonography, Mammary | 14 | 2023 | 241 | 3.650 |
Why?
|
Breast | 20 | 2024 | 1946 | 2.990 |
Why?
|
Calcinosis | 7 | 2023 | 1479 | 1.550 |
Why?
|
Burnout, Professional | 5 | 2022 | 711 | 1.360 |
Why?
|
Breast Diseases | 5 | 2016 | 436 | 1.250 |
Why?
|
Early Detection of Cancer | 16 | 2023 | 3236 | 1.230 |
Why?
|
Magnetic Resonance Imaging | 21 | 2024 | 36532 | 1.220 |
Why?
|
Radiographic Image Enhancement | 10 | 2023 | 872 | 1.200 |
Why?
|
Continuity of Patient Care | 3 | 2019 | 1078 | 1.060 |
Why?
|
Image Enhancement | 5 | 2016 | 2858 | 1.030 |
Why?
|
Retrospective Studies | 54 | 2024 | 81514 | 0.780 |
Why?
|
Radiology | 6 | 2022 | 2090 | 0.770 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2895 | 0.750 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2017 | 1224 | 0.630 |
Why?
|
Biopsy, Needle | 5 | 2022 | 1628 | 0.630 |
Why?
|
Mass Screening | 11 | 2022 | 5446 | 0.600 |
Why?
|
Mammary Glands, Human | 1 | 2019 | 199 | 0.570 |
Why?
|
Female | 71 | 2024 | 396112 | 0.540 |
Why?
|
Academic Medical Centers | 6 | 2023 | 2780 | 0.520 |
Why?
|
Diagnostic Errors | 2 | 2014 | 1275 | 0.500 |
Why?
|
Precancerous Conditions | 2 | 2019 | 976 | 0.500 |
Why?
|
Thoracic Diseases | 2 | 2016 | 99 | 0.480 |
Why?
|
Humans | 96 | 2024 | 765968 | 0.470 |
Why?
|
Carcinoma, Lobular | 4 | 2021 | 471 | 0.460 |
Why?
|
Sensitivity and Specificity | 12 | 2023 | 14652 | 0.460 |
Why?
|
Hospital Information Systems | 1 | 2016 | 396 | 0.450 |
Why?
|
Lymphatic Diseases | 1 | 2016 | 317 | 0.450 |
Why?
|
Quality Improvement | 3 | 2021 | 3853 | 0.440 |
Why?
|
Soft Tissue Infections | 1 | 2016 | 167 | 0.440 |
Why?
|
Axilla | 3 | 2023 | 615 | 0.430 |
Why?
|
Aftercare | 1 | 2019 | 911 | 0.410 |
Why?
|
Resilience, Psychological | 1 | 2020 | 806 | 0.410 |
Why?
|
Biopsy | 9 | 2022 | 6763 | 0.410 |
Why?
|
Carcinoma | 3 | 2019 | 2312 | 0.400 |
Why?
|
Diagnosis, Differential | 13 | 2020 | 12976 | 0.370 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1531 | 0.370 |
Why?
|
Contrast Media | 5 | 2019 | 5329 | 0.360 |
Why?
|
Abscess | 1 | 2014 | 606 | 0.350 |
Why?
|
Middle Aged | 39 | 2024 | 223009 | 0.350 |
Why?
|
Aged | 35 | 2024 | 171117 | 0.350 |
Why?
|
Adult | 39 | 2024 | 223044 | 0.340 |
Why?
|
Ultrasonography, Doppler | 2 | 2002 | 460 | 0.330 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2023 | 728 | 0.290 |
Why?
|
Vascular Diseases | 1 | 2016 | 1159 | 0.280 |
Why?
|
Neoplasms | 4 | 2023 | 22340 | 0.270 |
Why?
|
Artifacts | 3 | 2023 | 1893 | 0.270 |
Why?
|
Job Satisfaction | 2 | 2020 | 549 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9373 | 0.260 |
Why?
|
Aged, 80 and over | 17 | 2024 | 59489 | 0.260 |
Why?
|
Inflammatory Breast Neoplasms | 2 | 2021 | 150 | 0.260 |
Why?
|
Mastectomy, Segmental | 3 | 2000 | 964 | 0.260 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2418 | 0.250 |
Why?
|
Carcinoma, Ductal, Breast | 4 | 2024 | 1083 | 0.240 |
Why?
|
Reproducibility of Results | 7 | 2020 | 20124 | 0.240 |
Why?
|
Self Report | 3 | 2021 | 3770 | 0.240 |
Why?
|
Gadolinium DTPA | 2 | 2019 | 823 | 0.230 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 2024 | 920 | 0.220 |
Why?
|
Observer Variation | 4 | 2018 | 2615 | 0.210 |
Why?
|
Electronics | 2 | 2021 | 314 | 0.210 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3685 | 0.190 |
Why?
|
Lymph Nodes | 2 | 2023 | 3454 | 0.180 |
Why?
|
Thrombophlebitis | 1 | 2001 | 286 | 0.170 |
Why?
|
Faculty | 2 | 2021 | 384 | 0.170 |
Why?
|
Mastectomy | 3 | 2023 | 1847 | 0.170 |
Why?
|
Referral and Consultation | 3 | 2023 | 3615 | 0.170 |
Why?
|
Physicians | 3 | 2022 | 4588 | 0.160 |
Why?
|
Arm | 1 | 2002 | 589 | 0.160 |
Why?
|
Subcutaneous Fat | 1 | 2023 | 402 | 0.160 |
Why?
|
Neoplasm Invasiveness | 5 | 2024 | 3602 | 0.160 |
Why?
|
Predictive Value of Tests | 5 | 2023 | 15398 | 0.160 |
Why?
|
Neoplasms, Second Primary | 3 | 2018 | 1050 | 0.150 |
Why?
|
Computer Systems | 1 | 2000 | 466 | 0.150 |
Why?
|
Internship and Residency | 1 | 2018 | 5946 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 539 | 0.140 |
Why?
|
Reimbursement, Incentive | 1 | 2022 | 541 | 0.140 |
Why?
|
Abdominal Neoplasms | 1 | 1998 | 284 | 0.130 |
Why?
|
Nipples | 1 | 1998 | 222 | 0.130 |
Why?
|
Lymphatic Metastasis | 2 | 2023 | 2887 | 0.130 |
Why?
|
Workload | 2 | 2020 | 851 | 0.130 |
Why?
|
Pelvic Neoplasms | 1 | 1998 | 247 | 0.130 |
Why?
|
False Negative Reactions | 1 | 2017 | 573 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 197 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2021 | 718 | 0.120 |
Why?
|
Body Piercing | 1 | 2014 | 9 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 698 | 0.120 |
Why?
|
Cattle | 1 | 2020 | 3801 | 0.120 |
Why?
|
Algorithms | 3 | 2023 | 14071 | 0.110 |
Why?
|
Models, Animal | 1 | 2020 | 2120 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8923 | 0.110 |
Why?
|
User-Computer Interface | 1 | 2000 | 1405 | 0.110 |
Why?
|
Breast Implants | 1 | 2017 | 411 | 0.110 |
Why?
|
Suction | 1 | 2014 | 265 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2016 | 3356 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2002 | 1327 | 0.100 |
Why?
|
Pressure | 1 | 2016 | 1168 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2267 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39193 | 0.100 |
Why?
|
Ultrasonography | 5 | 2020 | 5993 | 0.100 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5849 | 0.100 |
Why?
|
Young Adult | 6 | 2017 | 59889 | 0.100 |
Why?
|
Testicular Diseases | 2 | 2003 | 72 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2023 | 3312 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2022 | 5302 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2352 | 0.090 |
Why?
|
Premenopause | 1 | 2013 | 1037 | 0.080 |
Why?
|
Risk Factors | 6 | 2017 | 74840 | 0.080 |
Why?
|
Drainage | 1 | 2014 | 1179 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2000 | 1941 | 0.070 |
Why?
|
Internet | 1 | 2000 | 3106 | 0.070 |
Why?
|
Postpartum Period | 1 | 2014 | 1205 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11206 | 0.060 |
Why?
|
Testicular Neoplasms | 2 | 2003 | 786 | 0.060 |
Why?
|
Breast Feeding | 1 | 2014 | 1364 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8703 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2710 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9338 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4873 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4353 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4255 | 0.060 |
Why?
|
Adolescent | 5 | 2017 | 88835 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8875 | 0.050 |
Why?
|
Patient Compliance | 1 | 2014 | 2692 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4058 | 0.050 |
Why?
|
Comorbidity | 2 | 2017 | 10563 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6823 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3529 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Calculi | 1 | 2003 | 48 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14751 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3965 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8297 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4863 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2517 | 0.050 |
Why?
|
Lithiasis | 1 | 2001 | 18 | 0.050 |
Why?
|
United States | 2 | 2021 | 72903 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4862 | 0.050 |
Why?
|
Germinoma | 1 | 2001 | 124 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20659 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15842 | 0.040 |
Why?
|
Teleradiology | 1 | 1999 | 52 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 1998 | 6942 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2000 | 15747 | 0.040 |
Why?
|
Vena Cava Filters | 1 | 2001 | 272 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2024 | 65188 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1144 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 862 | 0.040 |
Why?
|
Appointments and Schedules | 1 | 2021 | 444 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9081 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3432 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15880 | 0.030 |
Why?
|
Keratins | 1 | 2017 | 498 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5891 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 426 | 0.030 |
Why?
|
Lymphoma | 1 | 2024 | 1897 | 0.030 |
Why?
|
Polyps | 1 | 1997 | 200 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 697 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3537 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 21480 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2000 | 906 | 0.030 |
Why?
|
Endometrium | 1 | 1997 | 406 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6274 | 0.030 |
Why?
|
Internal Medicine | 1 | 2021 | 1064 | 0.030 |
Why?
|
Pregnancy | 2 | 2014 | 30260 | 0.030 |
Why?
|
Video Recording | 1 | 2018 | 969 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2910 | 0.030 |
Why?
|
Tamoxifen | 1 | 1997 | 963 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 1995 | 551 | 0.020 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1994 | 258 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6919 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41649 | 0.020 |
Why?
|
Spleen | 1 | 1997 | 2296 | 0.020 |
Why?
|
Radiology Information Systems | 1 | 1996 | 532 | 0.020 |
Why?
|
Fatty Liver | 1 | 1997 | 807 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3475 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 1995 | 779 | 0.020 |
Why?
|
Software | 2 | 2000 | 4462 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 1996 | 1019 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 1997 | 1534 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168764 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13266 | 0.020 |
Why?
|
Male | 6 | 2016 | 363698 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17533 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29922 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 1997 | 1378 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2001 | 2598 | 0.020 |
Why?
|
Risk Assessment | 2 | 2018 | 24282 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1994 | 1376 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54802 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9249 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9649 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11022 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1997 | 4958 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11868 | 0.010 |
Why?
|
Liver | 1 | 1997 | 7562 | 0.010 |
Why?
|
Time Factors | 2 | 2000 | 40065 | 0.010 |
Why?
|
Orchiectomy | 1 | 2001 | 460 | 0.010 |
Why?
|
Testis | 1 | 2001 | 780 | 0.010 |
Why?
|
Therapy, Computer-Assisted | 1 | 1999 | 265 | 0.010 |
Why?
|
X-Ray Intensifying Screens | 1 | 1996 | 32 | 0.010 |
Why?
|
Computer Terminals | 1 | 1996 | 41 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2475 | 0.010 |
Why?
|
Breast Neoplasms, Male | 1 | 1997 | 212 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1377 | 0.010 |
Why?
|
Reference Standards | 1 | 1997 | 1013 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 1996 | 544 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1997 | 1776 | 0.010 |
Why?
|
Research | 1 | 1999 | 1975 | 0.010 |
Why?
|
Lymphoma, Follicular | 1 | 1994 | 459 | 0.010 |
Why?
|
Intensive Care Units, Neonatal | 1 | 1996 | 855 | 0.000 |
Why?
|
Radiography, Interventional | 1 | 1995 | 1129 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1996 | 26346 | 0.000 |
Why?
|
Child | 1 | 1996 | 80564 | 0.000 |
Why?
|
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_